The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate‐risk HPV‐negative HNSCC

BACKGROUND: Only high‐risk tumors with extranodal extension (ENE) and/or positive surgical margins (PSM) benefit from adjuvant therapy (AT) with concurrent chemoradiation (CRT) compared to radiation therapy (RT) in locally advanced head and neck squamous cell carcinoma (HNSCC). Optimal treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales: Tasoulas, Jason, Lenze, Nicholas R., Farquhar, Douglas, P. Schrank, Travis, Shen, Colette, Shazib, M. Ali, Singer, Bart, Patel, Shetal, Grilley Olson, Juneko E., Hayes, David N., Gulley, Margaret L., Chera, Bhishamjit S., Hackman, Trevor, Olshan, Andrew F., Weiss, Jared, Sheth, Siddharth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124130/
https://www.ncbi.nlm.nih.gov/pubmed/33934525
http://dx.doi.org/10.1002/cam4.3883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124130/
https://www.ncbi.nlm.nih.gov/pubmed/33934525
http://dx.doi.org/10.1002/cam4.3883

Ejemplares similares